Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation Glucose Control Using a Next-Generation Automated Insulin Delivery Algorithm in Individuals With Type 1 Diabetes: EVOLUTION T1D

NCT07593625 is registered in ClinicalTrials.gov with Insulet Corporation as lead sponsor.

NCT NCT07593625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07593625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation Glucose Control Using a Next-Generation Automated Insulin Delivery Algorithm in Individuals With Type 1 Diabetes: EVOLUTION T1D
Lead sponsor
Insulet Corporation
Phase
Not applicable
Overall status
Recruiting
Start date
May 25, 2026
Completion date
February 1, 2027
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes (dm), type 1 diabetes, type 1 diabetes mellitus